Human Papillomavirus Vaccination Among Adults and Children in 5 US States. (November 2015)

• Record Type: Journal Article
• Authors: Du, Ping; Camacho, Fabian; McCall-Hosenfeld, Jennifer; Lengerich, Eugene; Meyers, Craig M.; Christensen, Neil D.
• Is Part Of: Journal of public health management and practice. Volume 21(2015)Supplement 6
• Publication Date: 2015-11
• Subjects: BRFSS -- health care access -- HPV vaccination -- human papillomavirus (HPV); Public health administration -- United States -- Periodicals; 253.6
• DOI: 10.1097/PHH.0000000000000271
• Languages: English
• ISSNs: 1078-4659

Abstract

Abstract : Context: The Centers for Disease Control and Prevention Advisory Committee for Immunization Practices has recommended human papillomavirus (HPV) vaccines for use in children and young adults for preventing HPV-related diseases, but HPV vaccine coverage is low in the United States. Objective: To assess HPV vaccination among US adults and children and to identify characteristics associated with HPV vaccination. Methods: We used the 2010 Behavioral Risk Factors Surveillance System data to examine HPV vaccine initiation and completion among adults aged 18 to 26 years and children aged 9 to 17 years in 5 US states. We performed a multivariate logistic regression to evaluate factors associated with HPV vaccination. Results: We assessed the HPV vaccination status of 706 women and 560 men and 2201 girls and 2292 boys. In 2010, a total of 258 (41.6%) women and 21 (4.3%) men had initiated HPV vaccination. Of those vaccinated women, 182 (75%) completed the 3-dose vaccine series. Rural residence (adjusted odds ratio [aOR] = 0.37) and not having a Papanicolaou test (aOR = 0.44) were negatively associated with HPV vaccine initiation among women. Women who were aged 18 to 20 years (aOR = 2.93) were more likely to complete HPV vaccination. A total of 612 (24.6%) girls and 86 (5.2%) boys received 1 or more doses of HPV vaccines; 308 (50.3%) vaccinated girls and 14 (10.8%) vaccinated boys completed the vaccine series. Younger age (9-12 years: aOR = 0.09) and not receiving a seasonal influenza vaccine (aOR = 0.44) were negatively related to HPV vaccine initiation in girls. Girls were less likely to initiate and complete HPV vaccination if their parents did not have a routine checkup within 1 year. Conclusion: HPV vaccination in the United States remains below the Healthy People 2020 objective (80%). To increase HPV vaccination, strategies still need to focus on improving access to HPV vaccines and utilization of health services. Abstract : This article assesses human papillomavirus (HPV) vaccination among adults and children in 5 US states and identifies characteristics associated with HPV vaccination.